Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 6
2004 4
2005 6
2006 5
2007 8
2008 10
2009 12
2010 8
2011 10
2012 14
2013 14
2014 13
2015 15
2016 15
2017 21
2018 15
2019 16
2020 24
2021 15
2022 18
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Results by year

Filters applied: . Clear all
Page 1
Corrigendum to 'Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment' Neoplasia, Volume 22, Issue 2 (2020) 111-119.
Kregel S, Wang C, Han X, Xiao L, Fernandez-Salas E, Bawa P, McCollum BL, Wilder-Romans K, Apel IJ, Cao X, Speers C, Wang S, Chinnaiyan AM. Kregel S, et al. Among authors: speers c. Neoplasia. 2024 May;51:100986. doi: 10.1016/j.neo.2024.100986. Epub 2024 Mar 15. Neoplasia. 2024. PMID: 38492449 Free PMC article. No abstract available.
The Effect of Wire Versus Magnetic Seed Localization on Lumpectomy Cavity Size.
Dykstra M, Thompson J, Aldous J, Jiang S, Hughes T, Hayman J, Dragovic A, Shah J, Chang A, Speers C, Sabel M, Dossett L, Schipper M, Jagsi R. Dykstra M, et al. Among authors: speers c. Pract Radiat Oncol. 2023 Dec 30:S1879-8500(23)00347-8. doi: 10.1016/j.prro.2023.12.004. Online ahead of print. Pract Radiat Oncol. 2023. PMID: 38161002
Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial.
Jagsi R, Barlow WE, Woodward WA, Connolly E, Mahtani R, Shumway D, Speers C, Stecklein SR, Zeidan Y, Zhang H, Sharma P, Pusztai L, Hortobagyi GN, Kalinsky K. Jagsi R, et al. Among authors: speers c. JAMA Oncol. 2023 Aug 1;9(8):1083-1089. doi: 10.1001/jamaoncol.2023.1984. JAMA Oncol. 2023. PMID: 37410451 Clinical Trial.
Does age affect outcome with breast cancer?
B Jackson E, Gondara L, Speers C, Diocee R, M Nichol A, Lohrisch C, A Gelmon K. B Jackson E, et al. Among authors: speers c. Breast. 2023 Aug;70:25-31. doi: 10.1016/j.breast.2023.06.001. Epub 2023 Jun 2. Breast. 2023. PMID: 37300985 Free PMC article.
Reply to V. Nardone et al.
Sjöström M, Fyles A, Liu FF, McCready D, Feng FY, Speers CW, Pierce LJ, Holmberg E, Fernö M, Malmström P, Karlsson P. Sjöström M, et al. Among authors: speers cw. J Clin Oncol. 2023 Aug 10;41(23):3959-3960. doi: 10.1200/JCO.23.00566. Epub 2023 Jun 6. J Clin Oncol. 2023. PMID: 37279434 No abstract available.
Reply to Y. Wang et al and Q. Sui et al.
Speers CW, Barlow WE, Symmans WF. Speers CW, et al. J Clin Oncol. 2023 Jul 20;41(21):3763-3764. doi: 10.1200/JCO.23.00722. Epub 2023 Jun 1. J Clin Oncol. 2023. PMID: 37262407 No abstract available.
Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial.
Stenmark Tullberg A, Sjöström M, Niméus E, Killander F, Chang SL, Feng FY, Speers CW, Pierce LJ, Kovács A, Lundstedt D, Holmberg E, Karlsson P. Stenmark Tullberg A, et al. Among authors: speers cw. Clin Cancer Res. 2023 May 1;29(9):1783-1793. doi: 10.1158/1078-0432.CCR-22-2746. Clin Cancer Res. 2023. PMID: 37071498 Free PMC article. Clinical Trial.
224 results